BALYASNY ASSET MANAGEMENT L.P. - KARUNA THERAPEUTICS INC ownership

KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 201 filers reported holding KARUNA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.18 and the average weighting 0.9%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of KARUNA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$18,227,733
+1265.3%
107,799
+1366.7%
0.04%
+1133.3%
Q1 2023$1,335,054
-78.6%
7,350
-76.8%
0.00%
-82.4%
Q4 2022$6,235,731
-32.3%
31,734
-56.4%
0.02%
-43.3%
Q2 2022$9,210,00072,8020.03%
Other shareholders
KARUNA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Sofinnova Investments, Inc. 1,952,441$150,963,00011.19%
Eventide Asset Management 901,077$69,671,0001.36%
First Light Asset Management, LLC 128,200$9,912,0001.02%
Prosight Management, LP 15,826$1,224,0000.58%
MOODY ALDRICH PARTNERS LLC 30,970$2,395,0000.50%
PFM Health Sciences, LP 137,960$10,667,0000.49%
Rock Springs Capital Management LP 244,106$18,874,0000.48%
Atika Capital Management LLC 73,500$5,683,0000.46%
Hood River Capital Management LLC 132,400$10,237,0000.44%
CATALYST PRIVATE WEALTH, LLC 5,006$387,0000.38%
View complete list of KARUNA THERAPEUTICS INC shareholders